Sign in
4/A

Changes in Ownership

CRISPR Therapeutics AG Filed Acc 0000899243-20-034324

Director sold 33,000 shares at an average $143.35 ($4,730,448)

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I In the form
Bolzon Bradley J PhD Director 2020-12-10 Sale −2,271 $140.62 $319,345 38,377 D
Bolzon Bradley J PhD Director 2020-12-10 Sale −6,648 $141.53 $940,923 31,729 D
Bolzon Bradley J PhD Director 2020-12-10 Sale −5,958 $142.42 $848,562 25,771 D
Bolzon Bradley J PhD Director 2020-12-10 Sale −2,223 $143.26 $318,462 23,548 D
Bolzon Bradley J PhD Director 2020-12-10 Sale −15,900 $144.85 $2,303,155 7,648 D
Open-market sales · 33,000 sh · avg $143.35 · $4,730,448
Loading xslF345X03/doc4a.xml…